Pendampingan Analisis Data Rekam Medis Terapi Plasma Konvalescen Bagi Pasien Covid-19:

Almas Nadifa; Arianto Marswita Rino; Reza Adityas  Trisnadi; Retno Widyastuti; Istiqomah Istiqomah

doi:10.26714/jipmi.v1iHKN.84

Penulis

Almas Nadifa Mahasiswa Fakultas Kedokteran Universitas Islam Sultan Agung Semarang
Arianto Marswita Rino Fakultas Kedokteran Universitas Islam Sultan Agung Semarang
Reza Adityas Trisnadi Fakultas Kedokteran Universitas Islam Sultan Agung Semarang
Retno Widyastuti Fakultas Kedokteran Universitas Islam Sultan Agung Semarang
Istiqomah Istiqomah Fakultas Kedokteran Universitas Islam Sultan Agung Semarang

DOI:

https://doi.org/10.26714/jipmi.v1iHKN.84

Kata Kunci:

COVID-19, plasma konvalesen, pendampingan, penyembuhan

Abstrak

Latar belakang: Coronavirus Disease 2019 (COVID-19) adalah penyakit menular akibat virus SARS-CoV-2 yang menjadi permasalahan global dengan morbiditas dan mortalitas tinggi untuk derajat sedang dan berat/kritis. Tujuan: untuk membantu penyembuhan pasien COVID-19 di Rumah Sakit Islam Sultan Agung Semarang. Metode: Pemberian terapi plasma konvalesen menggunakan studi analitik observasional dengan rancangan cross sectional yang dilakukan pengolahan data melalui Statistical Product and Service Solution (SPSS) dengan analisis univariat. Hasil: Pasien yang mendapatkan terapi menggunakan plasma konvalesen sebanyak 36 orang. Subyek berjenis kelamin laki-laki sebanyak 21 orang (58,3%) dan perempuan sebanyak 15 orang (41,7%). Pasien sembuh sebanyak 23 orang (63,9%) dan pasien yang meninggal sebanyak 13 orang (36,1%). Kesimpulan: Pendampingan mempercepat proses analisis data dengan menghasilkan informasi pasien COVID-19 yang mendapatkan terapi plasma konvalesen lebih banyak mengalami kesembuhan.

Kata Kunci: COVID-19, plasma konvalesen, pendampingan, penyembuhan

____________________________________________________________________________________________

Background: Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus which is a global problem with high morbidity and mortality to moderate and severe/critical degrees. Objective: to help cure COVID-19 patients at the Sultan Agung Islamic Hospital Semarang. Method: Giving convalescent plasma therapy using an analytic observational study with a cross-sectional design that performed data processing through Statistical Product and Service Solution (SPSS) with univariate analysis. Result: There were 36 patients who received convalescent plasma therapy. Subjects were male as many as 21 people (58,3%) and women as many as 15 people (41,7%). 23 patients recovered (63,9%) and 13 died (36,1%). Conclusion: Assistance speeds up the data analysis process by producing information that COVID-19 patients who receive convalescent plasma therapy experience more recovery.

Keywords: COVID-19, convalescent plasma, accompaniment, healing

Metrik

Metrik sedang dimuat ...

Biografi Penulis

Almas Nadifa, Mahasiswa Fakultas Kedokteran Universitas Islam Sultan Agung Semarang

Penulis pertama, penulis korespondensi

Referensi

Oddy C, McCaul J, Keeling P, et al. Pharmacological Predictors of Morbidity and Mortality in COVID-19. J Clin Pharmacol 2021; 61(10): 1286–1300.

Kementrian Kesehatan R. Pedoman Pencegahan dan Pengendalian COVID-19. Kementrian Kesehatan, RI 2020; 4: 1–214.

WHO. COVID-19 Weekly Epidemiological Update. World Heal Organ 2022; August: 1–33.

PDPI, PERKI, PAPDI, et al. Pedoman tatalaksana COVID-19 Edisi 3 Desember 2020. 2020.

Dwi Putera D, Suci Hardianti M. Efficacy and safety of convalescent plasma therapy in patients with COVID-19: a rapid review of case series. J thee Med Sci (Berkala Ilmu Kedokteran) 2020; 52: 134–147.

Abolghasemi H, Eshghi P, Majid A, et al. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information .

Mansourabadi A., Sadeghalvad M, Mohammadi-Motlagh H., et al. Mansourabadi, A. H., Sadeghalvad, M., Mohammadi-Motlagh, H. R., & Rezaei, N. (2020). The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19. Life Sciences, 258(July), 118185. https://doi.or. Life Sci; 258(July).

Devasenapathy, N., Ye, Z., Loeb, M., Fang, F., Najafabadi, B. T., Xiao, Y., Couban, R., Bégin, P., & Guyatt G. Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis. Cmaj 2020; 192(27): E745–E755.

O’Donnell MR, Grinsztejn B, Cummings MJ, et al. A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19. J Clin Invest; 131. Epub ahead of print 2021. DOI: 10.1172/JCI150646.

Salazar E, Christensen PA, Graviss EA, et al. Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Signi fi cantly Decreased Mortality. Am J Pathol 2020; 190: 2290–2303.

Klassen SA, Senefeld JW, Johnson PW, et al. The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis. Mayo Clin Proc 2021; 96: 1262–1275.

Joyner MJ, Senefeld JW, Klassen SA, et al. Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience. medRxiv Prepr Serv Heal Sci 2020; 1–31.

Ouyang J, Isnard S, Lin J, et al. Convalescent Plasma: The Relay Baton in the Race for Coronavirus Disease 2019 Treatment. Front Immunol; 11. Epub ahead of print 2020. DOI: 10.3389/fimmu.2020.570063.

Supadmi FRS. Literatur Review: Terapi Plasma Konvalesen Bagi Pasien Covid-19. Medica Arter 2021; 3: 53.

Widjaja Jordan SUPDPJHAKYB. Systematic literature review: Could plasma convalescent prevent death on COVID-19? J Pendidik Keperawatan Indones 2021; 7: 136–150.